233 related articles for article (PubMed ID: 15860755)
1. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.
Boyle MP; Noschese ML; Watts SL; Davis ME; Stenner SE; Lechtzin N
Am J Respir Crit Care Med; 2005 Jul; 172(2):212-7. PubMed ID: 15860755
[TBL] [Abstract][Full Text] [Related]
2. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis.
Boas SR; Hageman JR; Ho LT; Liveris M
J Cyst Fibros; 2009 Jul; 8(4):270-2. PubMed ID: 19447079
[TBL] [Abstract][Full Text] [Related]
3. Effect of high dose vitamin D3 therapy on serum vitamin D3 levels in vitamin D insufficient adults with cystic fibrosis.
Regalado Lam Chew Tun R; Porhownik N; Taback S; Oleschuk C
Clin Nutr ESPEN; 2018 Feb; 23():84-88. PubMed ID: 29460819
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults.
Pepper KJ; Judd SE; Nanes MS; Tangpricha V
Endocr Pract; 2009 Mar; 15(2):95-103. PubMed ID: 19342361
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
Simoneau T; Sawicki GS; Milliren CE; Feldman HA; Gordon CM
J Cyst Fibros; 2016 Mar; 15(2):234-41. PubMed ID: 26211605
[TBL] [Abstract][Full Text] [Related]
6. Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.
Vande Griend JP; McQueen RB; Linnebur SA; Vondracek SF
Pharmacotherapy; 2012 Feb; 32(2):135-41. PubMed ID: 22392422
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?
Qunibi WY; Abdellatif A; Sankar S; Hamdan Z; Lin FY; Ingle J; Cadena A; Gelfond J; Kasinath B
Clin Nephrol; 2010 Apr; 73(4):276-85. PubMed ID: 20353735
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency and its correction in children with sickle cell anaemia.
Wykes C; Arasaretnam A; O'Driscoll S; Farnham L; Moniz C; Rees DC
Ann Hematol; 2014 Dec; 93(12):2051-6. PubMed ID: 24981689
[TBL] [Abstract][Full Text] [Related]
11. Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Lark RK; Lester GE; Ontjes DA; Blackwood AD; Hollis BW; Hensler MM; Aris RM
Am J Clin Nutr; 2001 Mar; 73(3):602-6. PubMed ID: 11237938
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients.
Shah N; Bernardini J; Piraino B
Perit Dial Int; 2005; 25(4):362-6. PubMed ID: 16022093
[TBL] [Abstract][Full Text] [Related]
13. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate.
Green D; Carson K; Leonard A; Davis JE; Rosenstein B; Zeitlin P; Mogayzel P
J Pediatr; 2008 Oct; 153(4):554-9. PubMed ID: 18589445
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.
Aterrado S; Ono G; Kanehira-Mar S; Meier J; Swislocki A
Ann Pharmacother; 2015 Sep; 49(9):969-77. PubMed ID: 26104054
[TBL] [Abstract][Full Text] [Related]
15. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.
Dickerson RN; Berry SC; Ziebarth JD; Swanson JM; Maish GO; Minard G; Brown RO
Nutrition; 2015 Oct; 31(10):1219-23. PubMed ID: 26213135
[TBL] [Abstract][Full Text] [Related]
16. Difficulty Achieving Vitamin D Sufficiency With High-Dose Oral Repletion Therapy in Infants With Cholestasis.
Jensen M; Abu-El-Haija M; Bishop W; Rahhal RM
J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):187-9. PubMed ID: 25651487
[TBL] [Abstract][Full Text] [Related]
17. Treatment of vitamin D deficiency within a large integrated health care delivery system.
Stratton-Loeffler MJ; Lo JC; Hui RL; Coates A; Minkoff JR; Budayr A
J Manag Care Pharm; 2012 Sep; 18(7):497-505. PubMed ID: 22971203
[TBL] [Abstract][Full Text] [Related]
18. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
19. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.
Tangpricha V; Kelly A; Stephenson A; Maguiness K; Enders J; Robinson KA; Marshall BC; Borowitz D;
J Clin Endocrinol Metab; 2012 Apr; 97(4):1082-93. PubMed ID: 22399505
[TBL] [Abstract][Full Text] [Related]
20. Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients.
Green DM; Leonard AR; Paranjape SM; Rosenstein BJ; Zeitlin PL; Mogayzel PJ
J Cyst Fibros; 2010 Mar; 9(2):143-9. PubMed ID: 20117062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
